BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23935506)

  • 1. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
    Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
    PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63β upon transformation.
    Ben Khalifa Y; Teissier S; Tan MK; Phan QT; Daynac M; Wong WQ; Thierry F
    PLoS Pathog; 2011 Sep; 7(9):e1002256. PubMed ID: 21980285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
    Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
    Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
    J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
    Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
    J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E6/E7 and E6
    Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
    Front Immunol; 2019; 10():1676. PubMed ID: 31396215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout.
    Abboodi F; Buckhaults P; Altomare D; Liu C; Hosseinipour M; Banister CE; Creek KE; Pirisi L
    Virology; 2021 Feb; 554():9-16. PubMed ID: 33321328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1β.
    Ainouze M; Rochefort P; Parroche P; Roblot G; Tout I; Briat F; Zannetti C; Marotel M; Goutagny N; Auron P; Traverse-Glehen A; Lunel-Potencier A; Golfier F; Masson M; Robitaille A; Tommasino M; Carreira C; Walzer T; Henry T; Zanier K; Trave G; Hasan UA
    PLoS Pathog; 2018 Aug; 14(8):e1007158. PubMed ID: 30089163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
    Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.
    Sanduja S; Kaza V; Dixon DA
    Aging (Albany NY); 2009 Sep; 1(9):803-17. PubMed ID: 20157568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
    Ajiro M; Zheng ZM
    mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription.
    James CD; Fontan CT; Otoa R; Das D; Prabhakar AT; Wang X; Bristol ML; Morgan IM
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
    Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
    Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.
    Liu X; Disbrow GL; Yuan H; Tomaic V; Schlegel R
    J Virol; 2007 Nov; 81(22):12689-95. PubMed ID: 17804506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
    J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.
    Castagnino P; Kim HW; Lam LKM; Basu D; White EA
    J Virol; 2022 Nov; 96(22):e0132622. PubMed ID: 36342298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.